DiscoveryProbe™ FDA-approved Drug Library Plus

Drug discovery is often time-consuming, costly, and associated with a high failure rate. In contrast, drug repurposing offers significant advantages, including reduced development risk, shorter timelines, and lower research costs. Approved drugs, with well-defined bioactivity, pharmacokinetic profiles, and safety data, are ideal candidates for repurposing studies.

The DiscoveryProbe™ Approved Drug Library includes 2,607 compounds approved by major global regulatory agencies such as the FDA, EMA, HMA, CFDA, and PMDA. These compounds have demonstrated good safety profiles and are widely used in both in vitro and in vivo studies. This library is well-suited for high-throughput screening (HTS) and high-content screening (HCS), facilitating the rapid identification of novel drug targets and serving as a powerful tool to accelerate drug redevelopment efforts.

Potent Biological Activity: Features strong biological activity, high selectivity, and cell permeability, enabling effective inhibition or activation of targets.

Diverse Chemical Structures & Administration Routes: Offers a wide array of chemical structures and various administration routes (e.g., oral, intramuscular injection, intravenous injection).

Comprehensive Documentation: Provides detailed documentation, including information on compound potency, selectivity, and specific application areas.

Extensive Literature & Customer Validation: Backed by extensive and authoritative literature support and positive customer feedback.

Purity Verified: Compound purity is assured through NMR and HPLC analysis.